Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2026)

Updated

Drugs Made In America Acquisition's Current Assets came in at $69,184 for Q2 2026, up 39.1% from $49,726 a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition's Current Assets was $12,191, up 144.3% from FY2024.

  • Going back by year, Current Assets was $4,991 in FY2024.
  • The Q2 2026 figure represents the highest quarterly Current Assets since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - -
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - -
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn -
5 Kkr 81.05 Bn 47.53 Bn - -
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn -
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 130.16 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 1.39 Bn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 69,184.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69,184.00
Dec 31, 2025 12,191.00
Sep 30, 2025 28,196.00
Jun 30, 2025 49,726.00
Mar 31, 2025 71,019.00
Dec 31, 2024 4,991.00
API Access

Drugs Made In America Acquisition Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=DMAA&period=max&api_key=YOUR_API_KEY